COOPERSTONE BRENDA
SEC insider (Form 3/4/5 filer). CIK 0001931514. Director at Lexeo Therapeutics, Inc. (LXEO) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 25, 2026. Located in NEW YORK, NY.
Companies COOPERSTONE BRENDA has filed insider reports for
- Lexeo Therapeutics, Inc. (LXEO): Director
- Senti Biosciences, Inc. (SNTI): Director
COOPERSTONE BRENDA
CIK: 0001931514
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 25, 2026LXEO
Lexeo Therapeutics, Inc.
AwardDirectStock Option (right to buy)
35K shares- - Jun 26, 2025LXEO
Lexeo Therapeutics, Inc.
AwardDirectStock Option (right to buy)
25K shares- - Jun 25, 2025SNTI
Senti Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
22K shares- - Mar 7, 2025SNTI
Senti Biosciences, Inc.
AwardDirectStock Option (Right to Buy)
43.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jun 25, 2026 |  LXEO Lexeo Therapeutics, Inc. | Award Stock Option (right to buy) | 35,000 | - | - | Direct |
| Jun 26, 2025 | LXEO Lexeo Therapeutics, Inc. | Award Stock Option (right to buy) | 25,000 | - | - | Direct |
| Jun 25, 2025 |  SNTI Senti Biosciences, Inc. | Award Stock Option (Right to Buy) | 21,950 | - | - | Direct |
| Mar 7, 2025 | SNTI Senti Biosciences, Inc. | Award Stock Option (Right to Buy) | 43,900 | - | - | Direct |
1-4 of 4 transactions